|
市場調查報告書
藥品產業利用PLM的資訊流合理化
Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)
|
本報告已在2011年07月19日停止出版。
專門於多樣市場領域之調查分析的英國市調公司 Datamonitor Corporation(總公司:London),針對藥品產業利用PLM的資訊流合理化進行相關調查分析及預測,並出版報告書 "Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)" 。
本報告書內容包括:藥品產業PLM(產品生命週期管理)概要及市場動向、PLM銷售企業的特性等。內容綱要摘記如下:
概要
實施概要
從概念到實際市場:藥品產業產品生命週期管理
- 摘要
- 產品生命週期管理將改變新藥開發的生命週期
- PLM能有效因應該產業面臨的課題
- 藥品產業有幾個抑制PLM成功的因素
- 行動方案
- 明確決定PLM投資決策的策略性商業優勢
- 採取整體性的PLM策略
- 瞭解PLM如何創造藥品生命週期變化
對藥品產業而言的PLM技術最適化
- 摘要
- PLM技術應能因應藥品產業商業課題的需要
- 6種技術特性反映出PLM技術如何因應該產業的需求
- PLM技術採用狀況因地區而異
- 行動方案
- 提供顧客能符合商業目標需求的技術特性
- PLM的範圍集中在顧客日常生活的核心部分
- 以地區做為決定目標市場優先順序的判斷標準
利用PLM的流程複雜性管理
- 摘要
- 藥品生命週期管理技術愈發受到重視
- 生命科學PLM除了管理流程複雜性外,還應因應商業流程需要
- 將PLM定位為企業策略重點時容易成功
- 與技術開發企業合作是必要的策略
- 行動方案
- PLM必須有益於經營高層做決策
- 在擁有長期遠光的同時,還須決定短期的里程碑
- 必須視PLM不只是為了決定策略方針的重點解決方案
北美藥品生命週期管理預測:2006年至2012年(資料輯)
- 摘要
- 介紹
- 定義
- 北美藥品產業的PLM投資額
- 技術區隔別北美藥品產業的PLM投資額
- 美國藥品產業的PLM投資額:2006年至2012年
- 加拿大藥品產業的PLM投資額:2006年至2012年
- 領域別美國藥品產業的PLM投資額
- 地區別全球藥品產業的PLM投資額
西歐藥品生命週期管理預測:2006年至2012年(資料輯)
- 摘要
- 介紹
- 定義
- 西歐藥品產業的PLM投資額
- 技術區隔別西歐藥品產業的PLM投資額
- 領域別西歐藥品產業的PLM投資額
- 法國藥品產業的PLM投資額:2006年至2012年
- 英國藥品產業的PLM投資額:2006年至2012年
- 義大利藥品產業的PLM投資額:2006年至2012年
- 西班牙藥品產業的PLM投資額:2006年至2012年
- 瑞士藥品產業的PLM投資額:2006年至2012年
- 地區別全球藥品產業的PLM投資額
亞太地區藥品生命週期管理預測:2006年至2012年(資料輯)
- 摘要
- 介紹
- 定義
- 地區別全球藥品產業的PLM投資額
- 亞太地區藥品產業PLM投資額
- 中國藥品產業的PLM投資額:2006年至2012年
- 日本藥品產業的PLM投資額:2006年至2012年
- 領域別亞太地區藥品產業的PLM投資額
附錄
Abstract
Overview
Introduction
This report offers insight into PLM in the pharmaceutical industry, bringing
together all briefs published for this theme. The report covers market trends,
technological components which Datamonitor believes are key for this sector,
and four critical vendor attributes used by pharmaceutical companies to select
a PLM vendor.
Scope
- From Idea to Market: Product Lifecycle Management in the Pharmaceutical
Industry (Market Focus)
- Optimizing PLM Technology for the Pharmaceutical Industry (Technology
Focus)
- Managing Process Complexity in the Pharmaceutical Industry with PLM
(Strategy Focus)
- Pharmaceutical PLM Forecast in North America, Europe and APAC 2006-2012
(Databooks)
Report Highlights
- Pharmaceutical product lifecycle management technology is gaining momentum
- PLM addresses key business challenges facing the pharmaceutical industry
- PLM is successful when treated as an enterprise, strategic initiative
Reasons to Purchase
- Gain valuable industry insight into the market drivers and inhibitors for
product lifecycle management solutions in the life sciences market
- Align your go-to-market strategy with both the business and technology
needs of the pharmaceutical industry
- Quantify the current and projected market opportunity for PLM in the
pharmaceutical industry in North America, Western Europe, China and Japan.
Table of Contents
- Overview
- Catalyst
- Summary
- Methodology
- Executive Summary
- Introduction
- From Idea to Market: Product Lifecycle Management in the Pharmaceutical
Industry (Market Focus)
- Optimizing PLM Technology for the Pharmaceutical Industry (Technology
Focus)
- Managing Process Complexity with PLM (Strategy Focus)
- Pharmaceutical Product Lifecycle Management Forecast in North America
2006-2012 (Databook)
- Pharmaceutical Product Lifecycle Management Forecast in Western Europe
2006-2012
- Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012
- Table of Contents
- Table of figures
- Table of tables
- From Idea to Market: Product Lifecycle Management in the Pharmaceutical
Industry (market focus)
- Summary
- Product lifecycle management will transform the drug development
lifecycle process
- The nature of a drug' s lifecycle necessitates a PLM strategy
- PLM addresses key business challenges facing the pharmaceutical industry
- A greater focus on decreasing time to market is driving adoption of PLM
- Harmonizing product portfolios from M&A activities sets the stage
for PLM
- Reducing the challenges and cost associated with regulatory compliance
- The nature of the pharmaceutical drug pipeline is changing
- Complexity of pharmaceutical products is increasing
- The end of the Blockbuster era signifies more candidates in the
pipeline
- Successful PLM for the pharmaceutical industry prevails over several
constraining factors
- Repurposing software from other industries makes the pharmaceutical
industry suspicious
- The traditional autonomous-business-unit mentality inhibits adoption
of PLM
- PLM does not mean an antidote to new product development
- ACTIONS
- Articulate strategic business benefits of your PLM investment decisions
- Take a holistic approach to PLM
- Understand how PLM changes the lifecycle processes of a pharmaceutical
product
- Optimizing PLM Technology for the Pharmaceutical Industry (technology
Focus)
- Summary
- PLM technology should align to the pharmaceutical industry' s business
challenges
- Digitizing research information earlier in the product lifecycle is an
essential first step towards PLM
- The electronic notebook offers an entry point to a connected and
global product management system
- PLM links disparate technologies offering a single point of truth for
each drug in development
- Alleviating risks of non-compliance is a key application for PLM in
the pharmaceutical industry
- Six technology features reflect how PLM technology is aligned to the
industry
- Scalability places SOA at the center of a PLM solution
- A quality-by-design feature facilitates compliance
- PLM must integrate with ERP solutions
- A web-enabled PLM solution matches the global nature of most
pharmaceutical organizations
- A easy-to-configure user interface drives adoption amongst both
scientists and engineers
- The industry is most comfortable with non-hosted solutions
- PLM technology adoption differs across geographies
- Japan and China will experience the fastest growth in PLM
- ACTIONS
- Offer technology features that speak to the customer' s business goals
- Make PLM a core part of the customer' s every day life
- Consider geography as a criterion for prioritizing your target market
- Managing Process Complexity with PLM (Strategy Focus)
- Summary
- Pharmaceutical product lifecycle management technology is gaining
momentum
- A variety of challenges is fueling PLM adoption in the pharmaceutical
industry
- Cultural and technological barriers have inhibited wider adoption of
PLM in the pharmaceutical market
- PLM in the pharmaceutical industry is poised for strong growth and
vendors have an important role to play
- PLM in the life sciences should map to business processes, managing
process complexity
- Pharmaceutical companies produce what they discover, not what they
invent
- The pharmaceutical sector looks for PLM that can manage process
complexity
- PLM is successful when handled as an enterprise, strategic initiative
- As part of a company' s product development business strategy, PLM is
discussed among executives
- Collaboration, through enterprise PLM, breaks down individual silos
- Reducing drug development costs is a major strategic goal for
implementing enterprise PLM
- The benefits of an enterprise-wide PLM solution do come with risks
- A phased implementation approach is most likely for pharmaceutical
organizations
- Partnering with a technology vendor may be a necessary PLM strategy
- A long-term commitment to the project indicates a willingness to share
risk
- Innovative and flexible vendors will attract most business
- Implementation efficiency is an important vendor characteristic
- Track record of success reflects on a vendor' s reliability and
trustworthiness
- ACTIONS
- PLM must support executive-level decisions
- Have a long-term vision but establish short-term milestones
- Look beyond point solutions for a strategic approach to PLM
- Pharmaceutical Product Lifecycle Management Forecast in North America
2006-2012 (Databook)
- iNTRODUCTION
- Definitions
- Total PLM spending in the pharmaceutical industry in North America
- Total pharmaceutical PLM spending in North America by technology segment
- US PLM spending in the pharmaceutical industry 2006-2012
- Canada PLM spending in the pharmaceutical industry 2006-2012
- Total North America PLM spending in the pharmaceutical industry by sector
- Global PLM spending by geographic region
- Pharmaceutical Product Lifecycle Management Forecast in Western Europe
2006-2012 (Databook)
- iNTRODUCTION
- Definitions
- Total PLM spending in the pharmaceutical industry in Western Europe
- Total pharmaceutical PLM spending in Western Europe by technology segment
- Total pharmaceutical PLM spending in Western Europe by sector
- France PLM spending in the pharmaceutical industry 2006-2012
- Germany PLM spending in the pharmaceutical industry 2006-2012
- UK PLM spending in the pharmaceutical industry 2006-2012
- Italy PLM spending in the pharmaceutical industry 2006-2012
- Spain PLM spending in the pharmaceutical industry 2006-2012
- Switzerland PLM spending in the pharmaceutical industry 2006-2012
- Global PLM spending by geographic region
- Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012
(Databook)
- iNTRODUCTION
- Definitions
- Global PLM spending by geographic region
- Total PLM spending in the pharmaceutical industry in APAC
- China PLM spending in the pharmaceutical industry 2006-2012
- Japan PLM spending in the pharmaceutical industry 2006-2012
- Total APAC PLM spending in the pharmaceutical industry by sector
- APPENDIX
- Definitions
- Abbreviations
- Methodology
- Further reading
- Ask the analyst
- Datamonitor consulting
- Disclaimer
- List of Tables
- Table 1: Total PLM spending in the pharmaceutical industry in North
America
- Table 2: Total pharmaceutical PLM spending in North America by
technology segment
- Table 3: US PLM spending in the pharmaceutical industry 2006-2012
- Table 4: Canada PLM spending in the pharmaceutical industry 2006-2012
- Table 5: Total North America PLM spending in the pharmaceutical
industry by sector
- Table 6: Global PLM spending by geographic region
- Table 7: Total PLM spending in the pharmaceutical industry in Western
Europe
- Table 8: Total pharmaceutical PLM spending in Western Europe by
technology segment
- Table 9: Total pharmaceutical PLM spending in Western Europe by sector
2006-2012
- Table 10: France PLM spending in the pharmaceutical industry 2006-2012
- Table 11: Germany PLM spending in the pharmaceutical industry 2006-2012
- Table 12: UK PLM spending in the pharmaceutical industry 2006-2012
- Table 13: Italy PLM spending in the pharmaceutical industry 2006-2012
- Table 14: Spain PLM spending in the pharmaceutical industry 2006-2012
- Table 15: Switzerland PLM spending in the pharmaceutical industry
2006-2012
- Table 16: Global PLM spending by geographic region
- Table 17: Global PLM spending by geographic region
- Table 18: Total PLM spending in the pharmaceutical industry in APAC
- Table 19: China spending in the pharmaceutical industry 2006-2012
- Table 20: Japan PLM spending in the pharmaceutical industry 2006-2012
- Table 21: Total North America PLM spending in the pharmaceutical
industry by sector
- List of Figures
- Figure 1: The pharmaceutical product lifecycle is highly regulated,
more complex and longer than other industries
- Figure 2: Drug discovery licensing dependence of the top 10
pharmaceutical companies
- Figure 3: PLM spending in the pharmaceutical market is set for strong
growth over the next five years
- Figure 4: PLM in relation to ERP, CRM and BI
- Figure 5: PLM software must evolve to configurable packages to better
meet the pharmaceutical industry' s needs
- Figure 6: Global PLM spending by geographic region
- Figure 7: In the pharmaceutical industry, complexity in the process
defines the product
- Figure 8: Making a value proposition for PLM as a strategy in the
pharmaceutical product lifecycle
- Figure 9: As the Big Pharma begins to face its information management
needs, enterprise PLM investments will grow
- Figure 10: Examples of "must-have" and "nice-to-have" criteria
pharmaceutical companies use for selecting a PLM vendor as potential
partner
- Figure 11: Total PLM spending in the pharmaceutical industry in North
America
- Figure 12: Total pharmaceutical PLM spending in North America by
technology segment
- Figure 13: US PLM spending in the pharmaceutical industry 2006-2012
- Figure 14: Canada PLM spending in the pharmaceutical industry 2006-2012
- Figure 15: Total North America PLM spending in the pharmaceutical
industry by sector
- Figure 16: Global PLM spending by geographic region
- Figure 17: Total PLM spending in the pharmaceutical industry in
Western Europe
- Figure 18: Total pharmaceutical PLM spending in Western Europe by
technology segment
- Figure 19: Total pharmaceutical PLM spending in Western Europe by
sector 2006-2012
- Figure 20: France PLM spending in the pharmaceutical industry 2006-2012
- Figure 21: Germany PLM spending in the pharmaceutical industry
2006-2012
- Figure 22: UK PLM spending in the pharmaceutical industry 2006-2012
- Figure 23: Italy PLM spending in the pharmaceutical industry 2006-2012
- Figure 24: Spain PLM spending in the pharmaceutical industry 2006-2012
- Figure 25: Switzerland PLM spending in the pharmaceutical industry
2006-2012
- Figure 26: Global PLM spending by geographic region
- Figure 27: Global PLM spending by geographic region
- Figure 28: Total PLM spending in the pharmaceutical industry in APAC
- Figure 29: China spending in the pharmaceutical industry 2006-2012
- Figure 30: Japan PLM spending in the pharmaceutical industry 2006-2012
- Figure 31: Total APAC PLM spending in the pharmaceutical industry by
sector
|